Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Choice Behavior”

1,100 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,100 results

Large-scale testing (Phase 3)Looking for participantsNCT07218809
What this trial is testing

AZD5335 vs. Mirvetuximab Soravtansine in FRα-high and AZD5335 vs. Chemotherapy in FRα-low Platinum-resistant Ovarian Cancer

Who this might be right for
Epithelial Ovarian Cancer
AstraZeneca 1,100
Very early researchStudy completedNCT04296006
What this trial is testing

Neurobehavioral Mechanisms of Cocaine Choice

Who this might be right for
Cocaine Use Disorder
Joshua A. Lile, Ph.D. 15
Large-scale testing (Phase 3)UnknownNCT04433949
What this trial is testing

Best Supportive Care With or Without Low Dose Whole Lung Radiation Therapy for the Treatment of COVID-19

Who this might be right for
PneumoniaSevere Acute Respiratory SyndromeSymptomatic COVID-19 Infection Laboratory-Confirmed
Emory University 14
Not applicableStudy completedNCT03317535
What this trial is testing

Choice of Anesthesia for Endovascular Treatment of Acute Ischemic Stroke in Posterior Circulation

Who this might be right for
Posterior Circulation Brain Infarction
Beijing Tiantan Hospital 93
Not applicableStudy completedNCT00608504
What this trial is testing

Effects of Environmental Factors on Opiate Drug Choice in Opioid Dependent Individuals.

Who this might be right for
Heroin DependenceOpioid-Related Disorders
Wayne State University 16
Testing effectiveness (Phase 2)Study completedNCT02044874
What this trial is testing

Evaluate the Effect of Lorcaserin Hydrochloride on Smoking Cessation

Who this might be right for
Smoking Cessation
Arena Pharmaceuticals 603
Not applicableLooking for participantsNCT06275568
What this trial is testing

Accelerating Healthcare Engagement in Healthy Food Interventions - Food Rx in High Risk Pregnant Mothers With About Fresh and Community Health Choice

Who this might be right for
Nutrition in High-Risk Pregnancy
The University of Texas Health Science Center, Houston 620
Not applicableLooking for participantsNCT06080620
What this trial is testing

The Choice of Treatment Methods and Efficacy of LABC

Who this might be right for
Locally Advanced Breast Cancer
Peking Union Medical College Hospital 50
Not applicableStudy completedNCT04185623
What this trial is testing

Time Lag for Oocyte Denudation: A Better Choice for ICSI Outcome?!

Who this might be right for
Infertility, Female
Ahmed Saad 300
Testing effectiveness (Phase 2)Active Not RecruitingNCT04576455
What this trial is testing

A Study Evaluating the Efficacy and Safety of Giredestrant Compared With Physician's Choice of Endocrine Monotherapy in Participants With Previously Treated Estrogen Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer (acelERA Breast Cancer)

Who this might be right for
Estrogen Receptor-Positive, HER2-Negative, Locally Advanced or Metastatic Breast Cancer
Hoffmann-La Roche 303
Not applicableStudy completedNCT04383860
What this trial is testing

Sutures in Orbital Implants in Retinoblastoma Patients

Who this might be right for
Surgery--ComplicationsRetinoblastoma Bilateral
Sun Yat-sen University 132
Not applicableStudy completedNCT04336540
What this trial is testing

Increasing Availability of Lower Energy Meals vs. Menu Energy Labelling on Food Choice

Who this might be right for
Nutrition PoorObesityDiet, Healthy+1 more
University of Liverpool 2,091
Large-scale testing (Phase 3)Looking for participantsNCT06393374
What this trial is testing

Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)

Who this might be right for
Triple-Negative Breast Cancer
Merck Sharp & Dohme LLC 1,530
Post-approval studies (Phase 4)Study completedNCT04418479
What this trial is testing

SMart Angioplasty Research Team: CHoice of Optimal Anti-Thrombotic Strategy in Patients Undergoing Implantation of Coronary Drug-Eluting Stents 3

Who this might be right for
Coronary Artery Disease
Joo-Yong Hahn 5,506
Large-scale testing (Phase 3)Active Not RecruitingNCT06889688
What this trial is testing

Phase III Trial of Camrelizumab+Apatinib+Eribulin vs. Physician's Choice Chemotherapy in Advanced Triple-Negative Breast Cancer

Who this might be right for
Breast Cancer Stage IV
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 246
Not applicableStudy completedNCT03276546
What this trial is testing

SHARE-D: a Decision Tool to Help Patients Make Informed Lifestyle Choices

Who this might be right for
Health Behavior
Queen's University, Belfast 23
Testing effectiveness (Phase 2)Active Not RecruitingNCT04562870
What this trial is testing

Evaluate Single Agent Selinexor Versus Physician's Choice in Participants With Previously Treated Myelofibrosis

Who this might be right for
Myelofibrosis
Karyopharm Therapeutics Inc 112
Not applicableEnrolling By InvitationNCT06020027
What this trial is testing

Water is K'é: Multi-level Intervention to Promote Healthy Beverage Choices Among Navajo Families

Who this might be right for
WaterChild NutritionFamily Dynamics+4 more
Brigham and Women's Hospital 1,160
Large-scale testing (Phase 3)Study completedNCT02049905
What this trial is testing

Phase 3 Study to Treat Patients With Soft Tissue Sarcomas

Who this might be right for
Metastatic, Locally Advanced or Unresectable Soft Tissue Sarcoma
ImmunityBio, Inc. 433
Testing effectiveness (Phase 2)Looking for participantsNCT06992336
What this trial is testing

Circulating Tumor DNA Guided Boost Therapy in Early Triple Negative Breast Patients With Residual Disease After Neoadjuvant Therapy

Who this might be right for
Breast Cancer
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 411
Load More Results